Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase III Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women carrying a BRCA1 Germline Mutation
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared with the Physician's Choice of Endocrine Therapy Plus Everolimus in Patients with Estrogen Receptor-Positive, HER-Negative, Locally Advanced or Metastatic Breast Cancer
The COMPASSHER2 Trials COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer: COMPASSHER2 Residual Disease RD, a Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
Study Type: Treatment
Phase: III
NCTID: NCT04457596
Principal Investigator:
Anne O'Dea
A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score </= 18 Breast Cancer DEBRA
ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment ALTERNATE in postmenopausal women: A Phase III Study
A Study of the Safety and Effectiveness of the Mentor� Smooth and Textured Larger Size MemoryGel� Ultra High Profile UHP-L Breast Implants in Subjects who are undergoing Primary Breast Reconstruction or Revision Reconstruction ?Athena Study?
Study Type: Treatment
Phase: Device
NCTID: NCT02724371
Principal Investigator:
Richard Korentager